Ascendis Pharma stock poised for upside as Cantor Fitzgerald sees Yorvipath sales exceeding expectations

2 hours ago 1
Read Entire Article
  1. Homepage
  2. Finance
  3. Ascendis Pharma stock poised for upside as Cantor Fitzgerald sees Yorvipath sales exceeding expectations

Related

Regeneron stock price target raised to $815 from $810 at Guggenheim

Regeneron stock price target raised to $815 from $810 at Gug...

20 minutes ago 0
UBS initiates coverage on Pony AI stock with Buy rating, $20 price target

UBS initiates coverage on Pony AI stock with Buy rating, $20...

20 minutes ago 0
KBW raises Berkshire Hathaway stock price target to $740,000 on earnings beat

KBW raises Berkshire Hathaway stock price target to $740,000...

20 minutes ago 0

Trending

1. isaiah neyor
2. kenta maeda
3. las vegas news
4. smoke in las vegas today
5. chris stuckmann
6. california post
7. fires near las vegas
8. fire
9. wendy's wednesday meal
10. coaches poll

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

6 months ago 418
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

7 months ago 204
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

5 months ago 184
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

5 months ago 147
Sole mates: Find the perfect shoes for your fitness journey

Sole mates: Find the perfect shoes for your fitness journey

6 months ago 143
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved